J&J, Merck, Boston Scientific Debut Trio Of Splashy Takeovers Topping $3 Billion In Value

Johnson & Johnson (JNJ), Merck (MRK) and Boston Scientific (BSX) kicked off the year's biggest medical conference with a trio of splashy takeovers topping $3 billion in combined value.X Health care behemoth J&J is spending $2 billion to buy Ambrx (AMAM), Merck pledged to pay $680 million for Harpoon Therapeutics (HARP) and medtech player Boston Scientific (BSX) is coughing up $3.7 billion for Axonics (AXNX). Novartis (NVS) is also buying privately held Calypso Biotech for $250 million up front.The deals all ...